1. Home
  2. MFI vs GTBP Comparison

MFI vs GTBP Comparison

Compare MFI & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFI
  • GTBP
  • Stock Information
  • Founded
  • MFI 2002
  • GTBP 1965
  • Country
  • MFI Hong Kong
  • GTBP United States
  • Employees
  • MFI N/A
  • GTBP N/A
  • Industry
  • MFI
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFI
  • GTBP Health Care
  • Exchange
  • MFI NYSE
  • GTBP Nasdaq
  • Market Cap
  • MFI 9.9M
  • GTBP 4.9M
  • IPO Year
  • MFI 2024
  • GTBP N/A
  • Fundamental
  • Price
  • MFI $0.72
  • GTBP $2.15
  • Analyst Decision
  • MFI
  • GTBP Strong Buy
  • Analyst Count
  • MFI 0
  • GTBP 1
  • Target Price
  • MFI N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • MFI 297.3K
  • GTBP 238.1K
  • Earning Date
  • MFI 02-19-2025
  • GTBP 03-25-2025
  • Dividend Yield
  • MFI N/A
  • GTBP N/A
  • EPS Growth
  • MFI N/A
  • GTBP N/A
  • EPS
  • MFI N/A
  • GTBP N/A
  • Revenue
  • MFI $3,877,747.00
  • GTBP N/A
  • Revenue This Year
  • MFI N/A
  • GTBP N/A
  • Revenue Next Year
  • MFI N/A
  • GTBP N/A
  • P/E Ratio
  • MFI N/A
  • GTBP N/A
  • Revenue Growth
  • MFI N/A
  • GTBP N/A
  • 52 Week Low
  • MFI $0.51
  • GTBP $1.72
  • 52 Week High
  • MFI $14.49
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • MFI N/A
  • GTBP 42.94
  • Support Level
  • MFI N/A
  • GTBP $2.10
  • Resistance Level
  • MFI N/A
  • GTBP $2.39
  • Average True Range (ATR)
  • MFI 0.00
  • GTBP 0.21
  • MACD
  • MFI 0.00
  • GTBP 0.01
  • Stochastic Oscillator
  • MFI 0.00
  • GTBP 36.00

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: